Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 study

Journal:

The Lancet

Published:

2025-11-16

DOI:

10.1016/s0140-6736(25)01390-x

Affiliations:

8

Authors:

26

Go to article

Institutions	Authors	Share
Auro Vaccines, United States of America (USA)	13.000000 13.000000	0.50
PATH, United States of America (USA)	8.000000	0.31
Cincinnati Children's Hospital Medical Center (CCHMC), United States of America (USA)	2.000000	0.08
Uniformed Services University of the Health Sciences, United States of America (USA)	1.500000	0.06
PATH India, India	1.000000	0.04
Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), United States of America (USA)	0.500000	0.02

Interested in Clinical Sciences?